Copyright
©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Apr 10, 2016; 7(2): 131-134
Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.131
Published online Apr 10, 2016. doi: 10.5306/wjco.v7.i2.131
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?
Rossana Berardi, Mariangela Torniai, Agnese Savini, Silvia Rinaldi, Stefano Cascinu, Department of Medical Oncology, Università Politecnica delle Marche, 60100 Ancona, Italy
Author contributions: Berardi R, Torniai M, Savini A, Rinaldi S, Cascinu S contributed to equal in designing research, performing research, contributing new reagents or analytic tools, analyzing data, writing the paper; all authors contributed to the study, read and approved the final manuscript.
Conflict-of-interest statement: All authors declare that they have no competing interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Rossana Berardi, MD, Department of Medical Oncology, Università Politecnica delle Marche, Piazza Roma, Via Conca 71, 60100 Ancona, Italy. r.berardi@univpm.it
Telephone: +39-71-5965715 Fax: +39-71-5965053
Received: January 29, 2015
Peer-review started: January 31, 2015
First decision: March 6, 2015
Revised: January 18, 2016
Accepted: January 21, 2016
Article in press: January 22, 2016
Published online: April 10, 2016
Processing time: 434 Days and 3.3 Hours
Peer-review started: January 31, 2015
First decision: March 6, 2015
Revised: January 18, 2016
Accepted: January 21, 2016
Article in press: January 22, 2016
Published online: April 10, 2016
Processing time: 434 Days and 3.3 Hours
Core Tip
Core tip: Our paper stressed the importance of combined 68Ga-DOTATATE and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the management of gastro-entero-pancreatic tumors (GEP-NETs). In fact we underlined that the association of these functional imaging techniques showed an important role in redefining the disease after progression, especially in intermediate-grade GEP-NETs, allowing clinicians to choose the tailored therapeutic approach among available options.